OncoImmune nets $56m Series B

OncoImmune Inc, a biopharmaceutical company, has raised $56 million in Series B funding.

OncoImmune Inc, a biopharmaceutical company, has raised $56 million in Series B funding. The investors include HM Capital, 3E Bioventures Capital, Kaitai Capital, GBA Fund and GF Xinde.

Source: Press Release